• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Anette Breindl

Articles by Anette Breindl

Bench Press: BioWorld looks at translational medicine

June 24, 2019
By Anette Breindl
Two separate research groups, one at the Barcelona Institute of Science and Technology and one at Harvard Medical School, have discovered a way to predict 3D protein structures by focusing on mutated versions of the proteins that affected epistatic interactions. 
Read More

Half-used medicine cabinet means half-full glass for CLL

June 18, 2019
By Anette Breindl
AMSTERDAM – Since 2014, approvals and expanding indications for Bruton's tyrosine kinase (BTK) inhibitors Imbruvica (ibrutinib, Pharmacyclics LLC/Janssen Biotech Inc.) and Calquence (acalabrutinib, Astrazeneca plc), and Bcl-2 inhibitor Venclexta (venetoclax, Abbvie Inc./Roche AG) have given many chronic lymphocytic leukemia (CLL) patients chemotherapy-free treatment options. Many cancer patients dread chemotherapy almost as much as they dread their cancer, and frail patients may be unable to withstand the toxicities of chemotherapy and greatly prefer those chemotherapy-free regimens.
Read More

Gut microbe enzymes can convert blood from type A to type O

June 17, 2019
By Anette Breindl

Multiple approaches improve outlook for hemoglobinopathies

June 17, 2019
By Anette Breindl
AMSTERDAM – Sickle cell disease is "the most frequent red blood cell disorder worldwide," Jo Howard, of King's College London, told the audience at the 24th Congress of the European Hematology Association (EHA) on Friday. And with global migration patterns of the past decades, the disorder has gone from a tropical disease to global problem.
Read More

MCBS aims to separate wheat from chaff, expands to hematological cancers

June 17, 2019
By Anette Breindl
AMSTERDAM – "We are seeing a rapid explosion of new agents in malignancies," Nathan Cherny told the audience at the 23rd Congress of the European Hematology Association (EHA).
Read More

Bench Press: BioWorld looks at translational medicine

June 17, 2019
By Anette Breindl
Researchers at Columbia University have discovered that Vibrio cholerae has co-opted CRISPR Cas9 systems into transposons for horizontal gene transfer, and that those transposons were capable of site-specific gene editing without the need for double-stranded DNA breaks.
Read More

Gut microbe enzymes can convert blood from type A to type O

June 12, 2019
By Anette Breindl
Scientists have discovered a pair of gut microbial enzymes that worked in tandem to convert blood cells of the type A to those of type O by removing the surface molecule alpha-1,3-linked-N-acetylgalactosamine (GalNAc) from the surface of red blood cells.
Read More

Gut microbe enzymes can convert blood from type A to type O

June 11, 2019
By Anette Breindl
Scientists have discovered a pair of gut microbial enzymes that worked in tandem to convert blood cells of the type A to those of type O by removing the surface molecule alpha-1,3-linked-N-acetylgalactosamine (GalNAc) from the surface of red blood cells.
Read More

Bench Press: BioWorld looks at translational medicine

June 10, 2019
By Anette Breindl
Scientists at University Hospital RWTH Aachen have trained a neural network to recognize microsatellite instability (MSI)-high gastrointestinal tumors directly from histology, without the need for genetic or immunochemistry testing. 
Read More

Looking between the lines leads to neurofibromatosis insight

June 7, 2019
By Anette Breindl
Previous 1 2 … 102 103 104 105 106 107 108 109 110 … 393 394 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 17, 2025.
  • Art concept for bladder

    Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA

    BioWorld
    During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
  • Telomeres and DNA illustration

    23andme founder-led group outbids Regeneron for company

    BioWorld
    The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
  • Sarepta signage

    Elevidys’ second liver death hits Sarepta, sends DMD ripples

    BioWorld
    How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe